<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Curated"><PMID Version="1">31638922</PMID><DateCompleted><Year>2019</Year><Month>12</Month><Day>31</Day></DateCompleted><DateRevised><Year>2020</Year><Month>01</Month><Day>08</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1471-2334</ISSN><JournalIssue CitedMedium="Internet"><Volume>19</Volume><Issue>1</Issue><PubDate><Year>2019</Year><Month>Oct</Month><Day>21</Day></PubDate></JournalIssue><Title>BMC infectious diseases</Title><ISOAbbreviation>BMC Infect Dis</ISOAbbreviation></Journal><ArticleTitle>Continuous hemodiafiltration as a rescue therapy for patients with cardiopulmonary failure caused by enterovirus-71: a retrospective observational study in a PICU.</ArticleTitle><Pagination><StartPage>866</StartPage><MedlinePgn>866</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">866</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1186/s12879-019-4519-9</ELocationID><Abstract><AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Hand, foot and mouth disease (HFMD) remains a burdensome health issue in mainland China. Enterovirus71 (EV-A71) is the main pathogen of severe HFMD. Continuous hemofiltration improves fluid overload, restores kidney function and alleviates inflammatory reactions. The aim of the present study was to evaluate the effects of continuous veno-venous hemodiafiltration (CVVHDF) on severe HFMD caused by EV-A71(EV-A71-HFMD) in a pediatric intensive care unit (PICU).</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">A retrospective observational study was performed in a tertiary university PICU from January 2012 to December 2016. Children with severe EV-A71-HFMD complicated by cardiopulmonary failure were included. The patients were divided into a CVVHDF group and a conventional therapy (control) group (non-CVVHDF). The demographics, characteristics, and outcomes between the groups were collected and analyzed.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Twenty-nine patients with severe EV-A71-HFMD were enrolled. The 28-day mortality was 17.6% (3/17) in the CVVHDF group and 33.3% (4/12) in the non-CVVHDF group, with no statistical significance between the two groups (P&#x2009;=&#x2009;0.403). The median interval between CVVHDF initiation and PICU admission was 6 (4,8.5) hrs, and the median duration of CVVHDF was 48 (36, 64) hrs. The left ventricular ejection fraction (LVEF) and cardiac index (CI) in the CVVHDF group were improved after treatment. The plasma levels of catecholamines and renin-angiotensin-aldosterone system (RAAS) substances in the CVVHDF group were significantly decreased after treatment. The decreased catecholamines and RAAS substances included adrenalin (169.8 [145.5, 244.6] vs. 148.0 [109.0, 208.1] ng/L, P&#x2009;=&#x2009;0.033), dopamine (152.7 [97.0, 191.1] vs. 96.0 [68.0, 160.9] ng/L, P&#x2009;=&#x2009;0.026), angiotensin II (185.9 [125.2, 800.0] vs. 106.0 [90.8, 232.5] ng/L, P&#x2009;=&#x2009;0.047), aldosterone (165.7 [94.0, 353.3] vs. 103.3 [84.3, 144.3] ng/L, P&#x2009;=&#x2009;0.033), and renin (1.12 [0.74, 3.45] vs. 0.79 [0.52, 1.25] &#x3bc;g/L/h, P&#x2009;=&#x2009;0.029), CONCLUSIONS: CVVHDF reduced the levels of catecholamines and RAAS substances and improved cardiovascular function. Continuous hemodiafiltration may represent a potential therapy in patients with severe EV-A71-HFMD complicated with cardiopulmonary failure.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Chunxia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, No.355 Luding Road, Shanghai, 200062, Putuo District, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pediatric Critical Care, Shanghai Jiao Tong University, Shanghai, 200062, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cui</LastName><ForeName>Yun</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, No.355 Luding Road, Shanghai, 200062, Putuo District, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhu</LastName><ForeName>Yan</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, No.355 Luding Road, Shanghai, 200062, Putuo District, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Fei</ForeName><Initials>F</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, No.355 Luding Road, Shanghai, 200062, Putuo District, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Rong</LastName><ForeName>Qunfang</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, No.355 Luding Road, Shanghai, 200062, Putuo District, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Yucai</ForeName><Initials>Y</Initials><Identifier Source="ORCID">0000-0002-4905-3600</Identifier><AffiliationInfo><Affiliation>Department of Critical Care Medicine, Shanghai Children's Hospital, Shanghai Jiao Tong University, No.355 Luding Road, Shanghai, 200062, Putuo District, China. zyucai2018@163.com.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Institute of Pediatric Critical Care, Shanghai Jiao Tong University, Shanghai, 200062, China. zyucai2018@163.com.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>SHDC12014116</GrantID><Agency>New Advanced Technology Project at the Shanghai City Hospital Development Center</Agency><Country/></Grant><Grant><GrantID>17411968900</GrantID><Agency>Science and Technology Commission of Shanghai Municipality</Agency><Country/></Grant><Grant><GrantID>16411970300</GrantID><Agency>Science and Technology Commission of Shanghai Municipality</Agency><Country/></Grant><Grant><GrantID>DLY201618</GrantID><Agency>the Multicenter Clinical Research Program of Shanghai Jiao Tong University School of Medicine</Agency><Country/></Grant><Grant><GrantID>20171928</GrantID><Agency>Shanghai Municipal Education Commission-Gaofeng Clinical Medicine Grant support</Agency><Country/></Grant><Grant><GrantID>17XJ11018</GrantID><Agency>Talents Program of Shanghai Jiao Tong University School of Medicine</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D064888">Observational Study</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2019</Year><Month>10</Month><Day>21</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>BMC Infect Dis</MedlineTA><NlmUniqueID>100968551</NlmUniqueID><ISSNLinking>1471-2334</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D002395">Catecholamines</NameOfSubstance></Chemical><Chemical><RegistryNumber>11128-99-7</RegistryNumber><NameOfSubstance UI="D000804">Angiotensin II</NameOfSubstance></Chemical><Chemical><RegistryNumber>4964P6T9RB</RegistryNumber><NameOfSubstance UI="D000450">Aldosterone</NameOfSubstance></Chemical><Chemical><RegistryNumber>EC 3.4.23.15</RegistryNumber><NameOfSubstance UI="D012083">Renin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000450" MajorTopicYN="N">Aldosterone</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000804" MajorTopicYN="N">Angiotensin II</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002318" MajorTopicYN="N">Cardiovascular Diseases</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002395" MajorTopicYN="N">Catecholamines</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D002675" MajorTopicYN="N">Child, Preschool</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D002681" MajorTopicYN="N" Type="Geographic">China</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000079664" MajorTopicYN="Y">Continuous Renal Replacement Therapy</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029821" MajorTopicYN="Y">Enterovirus A, Human</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005500" MajorTopicYN="N">Follow-Up Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006232" MajorTopicYN="N">Hand, Foot and Mouth Disease</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName><QualifierName UI="Q000821" MajorTopicYN="Y">virology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D017583" MajorTopicYN="N">Hemodiafiltration</DescriptorName><QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D007223" MajorTopicYN="N">Infant</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D015278" MajorTopicYN="Y">Intensive Care Units, Pediatric</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D029424" MajorTopicYN="N">Pulmonary Disease, Chronic Obstructive</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000628" MajorTopicYN="Y">therapy</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012083" MajorTopicYN="N">Renin</DescriptorName><QualifierName UI="Q000097" MajorTopicYN="N">blood</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012084" MajorTopicYN="N">Renin-Angiotensin System</DescriptorName><QualifierName UI="Q000502" MajorTopicYN="N">physiology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D013318" MajorTopicYN="N">Stroke Volume</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D016896" MajorTopicYN="N">Treatment Outcome</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Cardiopulmonary failure</Keyword><Keyword MajorTopicYN="N">Child</Keyword><Keyword MajorTopicYN="N">Continuous veno-venous hemodiafiltration</Keyword><Keyword MajorTopicYN="N">Enterovirus71</Keyword><Keyword MajorTopicYN="N">Hand, foot and mouth disease</Keyword><Keyword MajorTopicYN="N">Mortality</Keyword></KeywordList><CoiStatement>The authors declare that they have no competing interests exist.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2018</Year><Month>12</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2019</Year><Month>9</Month><Day>27</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2019</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>1</Month><Day>1</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2019</Year><Month>10</Month><Day>21</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">31638922</ArticleId><ArticleId IdType="pmc">PMC6805415</ArticleId><ArticleId IdType="doi">10.1186/s12879-019-4519-9</ArticleId><ArticleId IdType="pii">10.1186/s12879-019-4519-9</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Wu JT, Jit M, Zheng Y, et al. Routine pediatric enterovirus 71 vaccination in China: a cost-effectiveness analysis. PLoS Med. 2016;13:e1001975. doi: 10.1371/journal.pmed.1001975.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pmed.1001975</ArticleId><ArticleId IdType="pmc">PMC4792415</ArticleId><ArticleId IdType="pubmed">26978565</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang SD, Li PQ, Li YM, et al. Clinical manifestations of severe enterovirus 71 infection and early assessment in a southern China population. BMC Infect Dis. 2017;17:153. doi: 10.1186/s12879-017-2228-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12879-017-2228-9</ArticleId><ArticleId IdType="pmc">PMC5316173</ArticleId><ArticleId IdType="pubmed">28212620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Q, MacDonald NE, Smith JC, et al. Severe enterovirus type 71 nervous system infections in children in the Shanghai region of China: clinical manifestations and implications for prevention and care. Pediatr Infect Dis J. 2014;33:482&#x2013;487. doi: 10.1097/INF.0000000000000194.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/INF.0000000000000194</ArticleId><ArticleId IdType="pubmed">24732390</ArticleId></ArticleIdList></Reference><Reference><Citation>Li XW, Ni X, Qian SY, et al. Chinese guidelines for the diagnosis and treatment of hand, foot and mouth disease (2018 edition) World J Pediatr. 2018;14:437&#x2013;447. doi: 10.1007/s12519-018-0189-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12519-018-0189-8</ArticleId><ArticleId IdType="pubmed">30280313</ArticleId></ArticleIdList></Reference><Reference><Citation>Goldstein SL. Continuous renal replacement therapy: mechanism of clearance, fluid removal, indications and outcomes. CurrOpinPediatr. 2011;23:181&#x2013;185.</Citation><ArticleIdList><ArticleId IdType="pubmed">21178623</ArticleId></ArticleIdList></Reference><Reference><Citation>Honore PM, Jacobs R, Joannes-Boyau O, et al. Newly designed CRRT membranes for sepsis and SIRS--a pragmatic approach for bedside intensivists summarizing the more recent advances: a systematic structured review. ASAIO J. 2013;59:99&#x2013;106. doi: 10.1097/MAT.0b013e3182816a75.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/MAT.0b013e3182816a75</ArticleId><ArticleId IdType="pubmed">23438770</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu JM, Wang JN, Tsai YC, et al. Cardiopulmonary manifestations of fulminant enterovirus 71 infection. Pediatrics. 2002;109:E26. doi: 10.1542/peds.109.2.e26.</Citation><ArticleIdList><ArticleId IdType="doi">10.1542/peds.109.2.e26</ArticleId><ArticleId IdType="pubmed">11826236</ArticleId></ArticleIdList></Reference><Reference><Citation>McMinn P, Stratov I, Nagarajan L, et al. Neurological manifestations of enterovirus 71 infection in children during an outbreak of hand, foot, and mouth disease in Western Australia. Clin Infect Dis. 2001;32:236&#x2013;242. doi: 10.1086/318454.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/318454</ArticleId><ArticleId IdType="pubmed">11170913</ArticleId></ArticleIdList></Reference><Reference><Citation>Cao L, Geng W, Xu M, et al. Effect of continuous hemofiltration on inflammatory mediators and hemodynamics in children with severe hand, foot and mouth disease. Zhongguo Dang Dai Er Ke Za Zhi. 2016;18:219&#x2013;223.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7390000</ArticleId><ArticleId IdType="pubmed">26975818</ArticleId></ArticleIdList></Reference><Reference><Citation>Nguyen NT, Pham HV, Hoang CQ, et al. Epidemiological and clinical characteristics of children who died from hand, foot and mouth disease in Vietnam, 2011. BMC Infect Dis. 2014;14:341. doi: 10.1186/1471-2334-14-341.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1471-2334-14-341</ArticleId><ArticleId IdType="pmc">PMC4068316</ArticleId><ArticleId IdType="pubmed">24942066</ArticleId></ArticleIdList></Reference><Reference><Citation>Qui P, Khanh T, Trieu H, et al. Intravenous magnesium sulfate for the management of severe hand, foot, and mouth disease with autonomic nervous system dysregulation in Vietnamese children: study protocol for a randomized controlled trial. Trials. 2016;17:98. doi: 10.1186/s13063-016-1215-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13063-016-1215-6</ArticleId><ArticleId IdType="pmc">PMC4759733</ArticleId><ArticleId IdType="pubmed">26896318</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao H, Wang F, Xiong X, et al. Clinical benefits of high-volume hemofiltration in critically ill pediatric patients with severe sepsis: aretrospective cohort study. Blood Purif. 2018;45:18&#x2013;27. doi: 10.1159/000481249.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000481249</ArticleId><ArticleId IdType="pubmed">29161713</ArticleId></ArticleIdList></Reference><Reference><Citation>Miao H, Shi J, Wang C, et al. Continuous renal replacement therapy in pediatric severe sepsis: a propensity score-matched prospective multicenter cohort study in the PICU. Crit Care Med. 2019. 10.1097/CCM.0000000000003901.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6750150</ArticleId><ArticleId IdType="pubmed">31369427</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Zhang YC, Kang YL, et al. High-volume hemofiltration in critically ill patients with secondary hemophagocytic lymphohistiocytosis/macrophage activation syndrome: a prospective study in the PICU. PediatrCrit Care Med. 2016;17:e437&#x2013;e443. doi: 10.1097/PCC.0000000000000896.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/PCC.0000000000000896</ArticleId><ArticleId IdType="pubmed">27487914</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang LY, Lin TY, Hsu KH, et al. Clinical features and risk factors of pulmonary oedema after enterovirus-71-related hand, foot, and mouth disease. Lancet. 1999;354:1682&#x2013;1686. doi: 10.1016/S0140-6736(99)04434-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(99)04434-7</ArticleId><ArticleId IdType="pubmed">10568570</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang F, Jan S, Chen P, et al. Left ventricular dysfunction in children with fulminant enterovirus 71 infection: an evaluation of the clinical course. Clin Infect Dis. 2002;34:1020&#x2013;1024. doi: 10.1086/339445.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/339445</ArticleId><ArticleId IdType="pubmed">11880970</ArticleId></ArticleIdList></Reference><Reference><Citation>Clinical Experts Group of the Ministry of Health for Hand, Foot, and Mouth Disease Experts consensus on rescue and treatment of severe cases with enterovirus 71 (EV71) infection. ZhonghuaErKe Za Zhi. 2011;49:675&#x2013;678.</Citation><ArticleIdList><ArticleId IdType="pubmed">22176902</ArticleId></ArticleIdList></Reference><Reference><Citation>Anzai T, Lai NC, Gao M, et al. Dissociation between regional dysfunction and beta-adrenergic receptor signaling in heart failure. Am J Physiol. 1998;275:H1267&#x2013;H1273.</Citation><ArticleIdList><ArticleId IdType="pubmed">9746475</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao P, Zheng R, Xue L, et al. Early fluid resuscitation and high volumehemofiltration decrease septic shock progression in swine. Biomed Res Int. 2015;2015:181845.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4620416</ArticleId><ArticleId IdType="pubmed">26543849</ArticleId></ArticleIdList></Reference><Reference><Citation>Dang Hong-Xing, Liu Cheng-Jun, Li Jing, Chen Shi-Jiao, Xu Feng. Clinical Significance and Prognostic Effect of Serum 25-hydroxyvitamin D Concentrations in Critical and Severe Hand, Foot and Mouth Disease. Nutrients. 2017;9(5):478. doi: 10.3390/nu9050478.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/nu9050478</ArticleId><ArticleId IdType="pmc">PMC5452208</ArticleId><ArticleId IdType="pubmed">28489032</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y, Xiong X, Wang F, et al. Continuous hemofiltration improves the prognosis of bacterial sepsis complicated by liver dysfunction in children. BMC Pediatr. 2018;18:269. doi: 10.1186/s12887-018-1243-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12887-018-1243-3</ArticleId><ArticleId IdType="pmc">PMC6087006</ArticleId><ArticleId IdType="pubmed">30098593</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang Y, Li X, Zhu X, et al. Clinical characteristics and treatment of severe encephalitis associated with neurogenic pulmonary edema caused by enterovirus 71 in China. World J Emerg Med. 2010;1:108&#x2013;113.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4129752</ArticleId><ArticleId IdType="pubmed">25214951</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao YT, Wang SM, Wang JR, et al. Norepinephrine andepinephrineenhanced the infectivity of enterovirus 71. PLoS One. 2015;10:e0135154. doi: 10.1371/journal.pone.0135154.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0135154</ArticleId><ArticleId IdType="pmc">PMC4529162</ArticleId><ArticleId IdType="pubmed">26252639</ArticleId></ArticleIdList></Reference><Reference><Citation>Lei Z, Li B, Li H, et al. Relationship between catecholamine level and gene polymorphism of &#x3b2;1 adrenergic receptor G1165C in children with EV71 infection in hand foot and mouth disease. Asian Pac J Trop Med. 2017;10:473&#x2013;477. doi: 10.1016/j.apjtm.2017.05.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.apjtm.2017.05.006</ArticleId><ArticleId IdType="pubmed">28647185</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellomo R, McGrath B, Boyce N. Effect of continuous venovenous hemofiltration with dialysis on hormone and catecholamine clearance in critically ill patients with acute renal failure. Crit Care Med. 1994;22:833&#x2013;837. doi: 10.1097/00003246-199405000-00020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00003246-199405000-00020</ArticleId><ArticleId IdType="pubmed">8181293</ArticleId></ArticleIdList></Reference><Reference><Citation>Blake P, Hasegawa Y, Khosla MC, et al. Isolation of "myocardial depressant factor(s)" from the ultrafiltrate of heart failure patients with acute renal failure. ASAIO J. 1996;42:M911&#x2013;M915. doi: 10.1097/00002480-199609000-00127.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00002480-199609000-00127</ArticleId><ArticleId IdType="pubmed">8945020</ArticleId></ArticleIdList></Reference><Reference><Citation>Siebeck M, Dimski T, Brandenburger T, et al. Super high-flux continuous venovenoushemodialysisusing regional citrate anticoagulation: long-term stability of middle molecule clearance. TherApher Dial. 2018;22:355&#x2013;364. doi: 10.1111/1744-9987.12656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/1744-9987.12656</ArticleId><ArticleId IdType="pubmed">29417731</ArticleId></ArticleIdList></Reference><Reference><Citation>Victorio CB, Xu Y, Ng Q, et al. A clinically authentic mouse model of enterovirus 71(EV-A71) &#x2013;induced neurogenic pulmonary oedema. Sci Rep. 2016;6:28876. doi: 10.1038/srep28876.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/srep28876</ArticleId><ArticleId IdType="pmc">PMC4928123</ArticleId><ArticleId IdType="pubmed">27357918</ArticleId></ArticleIdList></Reference><Reference><Citation>Morena M, Delbosc S, Dupuy AM, et al. Overproduction of reactive oxygen species in end-stage renal disease patients: a potential component of hemodialysis-associated inflammation. Hemodial Int. 2005;9:37&#x2013;46. doi: 10.1111/j.1492-7535.2005.01116.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1492-7535.2005.01116.x</ArticleId><ArticleId IdType="pubmed">16191052</ArticleId></ArticleIdList></Reference><Reference><Citation>Patten RD, Kronenberg MW, Benedict CR, et al. Acute and long-term effects of the angiotensin-converting enzyme inhibitor, enalapril, on adrenergic activity and sensitivity during exercise in patients with left ventricular systolic dysfunction. Am Heart J. 1997;134:37&#x2013;43. doi: 10.1016/S0002-8703(97)70104-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0002-8703(97)70104-2</ArticleId><ArticleId IdType="pubmed">9266781</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>